Two Sigma Securities’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-18,059
| Closed | -$12.6K | – | 2320 |
|
2023
Q4 | $12.6K | Sell |
18,059
-11,649
| -39% | -$8.16K | ﹤0.01% | 1223 |
|
2023
Q3 | $20.5K | Buy |
+29,708
| New | +$20.5K | ﹤0.01% | 1029 |
|
2023
Q2 | – | Sell |
-352
| Closed | -$2.85K | – | 2069 |
|
2023
Q1 | $2.85K | Sell |
352
-48
| -12% | -$389 | ﹤0.01% | 1249 |
|
2022
Q4 | $4.74K | Sell |
400
-173
| -30% | -$2.05K | ﹤0.01% | 1248 |
|
2022
Q3 | $8K | Sell |
573
-765
| -57% | -$10.7K | ﹤0.01% | 1222 |
|
2022
Q2 | $47K | Buy |
+1,338
| New | +$47K | ﹤0.01% | 897 |
|
2022
Q1 | – | Sell |
-327
| Closed | -$14K | – | 1685 |
|
2021
Q4 | $14K | Buy |
+327
| New | +$14K | ﹤0.01% | 952 |
|
2018
Q3 | – | Sell |
-199
| Closed | -$45K | – | 1703 |
|
2018
Q2 | $45K | Buy |
+199
| New | +$45K | ﹤0.01% | 940 |
|
2018
Q1 | – | Sell |
-240
| Closed | -$74K | – | 1690 |
|
2017
Q4 | $74K | Buy |
+240
| New | +$74K | ﹤0.01% | 784 |
|
2017
Q3 | – | Sell |
-200
| Closed | -$73K | – | 1251 |
|
2017
Q2 | $73K | Buy |
+200
| New | +$73K | 0.01% | 682 |
|